Alpha mangostin inhibits proliferation, migration, and invasion of human breast cancer cells via STAT3 inhibition
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F23%3A00079715" target="_blank" >RIV/00159816:_____/23:00079715 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216224:14110/23:00133682
Výsledek na webu
<a href="https://www.sciencedirect.com/science/article/pii/S2667394023000035?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S2667394023000035?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.adcanc.2023.100089" target="_blank" >10.1016/j.adcanc.2023.100089</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Alpha mangostin inhibits proliferation, migration, and invasion of human breast cancer cells via STAT3 inhibition
Popis výsledku v původním jazyce
Signal Transducer and Activator of Transcription 3 (STAT3) is an identified critical protein associated with the progression of cancer. Alpha mangostin (alpha-M), a powerful dietary xanthone found to have anti-cancer properties against various cancers. However, the precise mechanism of its anti-cancer activity is not fully understood. Therefore, the current work hypothesized that targeting STAT3 with alpha-M inhibits the migration, invasion, and proliferation of breast cancer cells. Firstly, we evaluated the binding affinity of alpha-M/STAT3 complex using molecular dynamic simulations (MDS) and further we determined the likely underlying mechanism of STAT3 through in-vitro experiments. alpha-M treatment affected the levels of STAT3 phosphorylation, hnRNP-A1, PKM2, and EMT markers. alpha-M stimulation in breast cancer cells also resulted in suppressed migratory and invasive behaviour. More importantly, the treatment also affected the Ki67 and BrdU positive cells. In summary, we found the anti-migratory and anti-proliferative actions of alpha-M in breast cancer cells via STAT3 inhibition. Also, the study significantly adds a new nutraceutical for therapeutic intervention of invasive breast cancer.
Název v anglickém jazyce
Alpha mangostin inhibits proliferation, migration, and invasion of human breast cancer cells via STAT3 inhibition
Popis výsledku anglicky
Signal Transducer and Activator of Transcription 3 (STAT3) is an identified critical protein associated with the progression of cancer. Alpha mangostin (alpha-M), a powerful dietary xanthone found to have anti-cancer properties against various cancers. However, the precise mechanism of its anti-cancer activity is not fully understood. Therefore, the current work hypothesized that targeting STAT3 with alpha-M inhibits the migration, invasion, and proliferation of breast cancer cells. Firstly, we evaluated the binding affinity of alpha-M/STAT3 complex using molecular dynamic simulations (MDS) and further we determined the likely underlying mechanism of STAT3 through in-vitro experiments. alpha-M treatment affected the levels of STAT3 phosphorylation, hnRNP-A1, PKM2, and EMT markers. alpha-M stimulation in breast cancer cells also resulted in suppressed migratory and invasive behaviour. More importantly, the treatment also affected the Ki67 and BrdU positive cells. In summary, we found the anti-migratory and anti-proliferative actions of alpha-M in breast cancer cells via STAT3 inhibition. Also, the study significantly adds a new nutraceutical for therapeutic intervention of invasive breast cancer.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30204 - Oncology
Návaznosti výsledku
Projekt
<a href="/cs/project/LX22NPO5107" target="_blank" >LX22NPO5107: Národní ústav pro neurologický výzkum</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2023
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
ADVANCES IN CANCER BIOLOGY-METASTASIS
ISSN
2667-3940
e-ISSN
2667-3940
Svazek periodika
7
Číslo periodika v rámci svazku
JUL 2023
Stát vydavatele periodika
NL - Nizozemsko
Počet stran výsledku
11
Strana od-do
100089
Kód UT WoS článku
001136029700001
EID výsledku v databázi Scopus
—